Meribank Biotech has signed a letter of intent with Ahead Medicine and Apexcella Biomedical, focusing on optimizing allogeneic natural killer (NK) cell manufacturing and building an AI-based immune cell detection platform. The collaboration aims to...
The article requires paid subscription. Subscribe Now


